E36 (Potassium Citrate Extended-Release 15 mEq (1620 mg))
Pill with imprint E36 is Yellow, Rectangle and has been identified as Potassium Citrate Extended-Release 15 mEq (1620 mg). It is supplied by Eywa Pharma Inc..
Potassium citrate is used in the treatment of renal tubular acidosis; nephrolithiasis and belongs to the drug class urinary pH modifiers. Risk cannot be ruled out during pregnancy. Potassium citrate 15 mEq (1620 mg) is not a controlled substance under the Controlled Substances Act (CSA).
Images for E36
Potassium Citrate Extended-Release
- Imprint
- E36
- Strength
- 15 mEq (1620 mg)
- Color
- Yellow
- Shape
- Rectangle
- Availability
- Prescription only
- Drug Class
- Urinary ph modifiers
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Eywa Pharma Inc.
- National Drug Code (NDC)
- 71930-0050
Related Images for "E36"
More about potassium citrate
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Pricing & Coupons
- En Español
- 6 Reviews
- Drug class: urinary pH modifiers
Consumer resources
- Other brands
- Urocit-K
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.